Yesterday, Oct. 8, 2015, 33 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $370.00 to $7,976,778.07.

Highlighted Stocks Traded by Insiders:

Bristol-Myers Squibb Company (BMY) - FREE Research Report

Andreotti Lamberto, who is Director at Bristol-Myers Squibb Company, sold 23,200 shares at $60.86 on Oct. 8, 2015. Following this transaction, the Director owned 524,252 shares meaning that the stake was reduced by 4.24% with the 23,200-share transaction.

The shares most recently traded at $60.91, up $0.05, or 0.08% since the insider transaction. Historical insider transactions for Bristol-Myers Squibb Company go as follows:

  • 4-Week # shares sold: 23,200
  • 12-Week # shares sold: 23,200
  • 24-Week # shares sold: 40,172

The average volume for Bristol-Myers Squibb Company has been 7.5 million shares per day over the past 30 days. Bristol-Myers Squibb Company has a market cap of $101.0 billion and is part of the health care sector and drugs industry. Shares are up 2.51% year-to-date as of the close of trading on Thursday.

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The stock currently has a dividend yield of 2.44%. The company has a P/E ratio of 56.6. Currently, there are 9 analysts who rate Bristol-Myers Squibb Company a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BMY - FREE

TheStreet Quant Ratings rates Bristol-Myers Squibb Company as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow. Get the full Bristol-Myers Squibb Company Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Tiptree Financial (TIPT) - FREE Research Report

Barnes Michael Gene, who is Executive Chairman at Tiptree Financial, bought 5,000 shares at $7.02 on Oct. 8, 2015. Following this transaction, the Executive Chairman owned 3.2 million shares meaning that the stake was boosted by 0.16% with the 5,000-share transaction.

The shares most recently traded at $6.91, down $0.11, or 1.62% since the insider transaction. Historical insider transactions for Tiptree Financial go as follows:

  • 4-Week # shares bought: 39,700
  • 12-Week # shares bought: 76,360
  • 24-Week # shares bought: 303,374

The average volume for Tiptree Financial has been 40,200 shares per day over the past 30 days. Tiptree Financial has a market cap of $237.8 million and is part of the financial sector and insurance industry. Shares are down 12.1% year-to-date as of the close of trading on Thursday.

TipTree Financial Inc., formerly Care Investment Trust, operates as a real estate investment trust (REIT). It engages in originating and acquiring healthcare-related real estate and commercial mortgage debt. The stock currently has a dividend yield of 1.4%.

Exclusive Offer: Get the latest Stock Analysis on TIPT - FREE

TheStreet Quant Ratings rates Tiptree Financial as a sell. The company's weaknesses can be seen in multiple areas, such as its generally high debt management risk, disappointing return on equity, weak operating cash flow, poor profit margins and generally disappointing historical performance in the stock itself. Get the full Tiptree Financial Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Continental Resources (CLR) - FREE Research Report

Owen Steven K, who is SVP, Land at Continental Resources, bought 25 shares at $28.22 on Oct. 8, 2015. Following this transaction, the SVP, Land owned 85,110 shares meaning that the stake was boosted by 0.03% with the 25-share transaction.

The shares most recently traded at $37.04, up $8.82, or 23.81% since the insider transaction. Historical insider transactions for Continental Resources go as follows:

  • 4-Week # shares bought: 139,621
  • 4-Week # shares sold: 6,666
  • 12-Week # shares bought: 139,621
  • 12-Week # shares sold: 6,666
  • 24-Week # shares bought: 139,621
  • 24-Week # shares sold: 21,946

The average volume for Continental Resources has been 4.7 million shares per day over the past 30 days. Continental Resources has a market cap of $13.6 billion and is part of the basic materials sector and energy industry. Shares are down 2.11% year-to-date as of the close of trading on Thursday.

Continental Resources, Inc. explores, develops, and produces crude oil and natural gas properties in the north, south, and east regions of the United States. The company has a P/E ratio of 26.0. Currently, there are 10 analysts who rate Continental Resources a buy, 1 analyst rates it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CLR - FREE

TheStreet Quant Ratings rates Continental Resources as a hold. Among the primary strengths of the company is its expanding profit margins over time. At the same time, however, we also find weaknesses including deteriorating net income, generally higher debt management risk and disappointing return on equity. Get the full Continental Resources Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Data for this article provided by Zacks Investment Research